Bleakley Financial Group »

Tango Therapeutics shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $259k 12k 20.92
2024-12-31 $40k 13k 3.09
2024-09-30 $111k 14k 7.70
2024-06-30 $138k 16k 8.58

More positions owned by Bleakley Financial Group

Ishares Tr Core S&p500 Etf (IVV)
Sprott Asset Management Physical Gold An (CEF)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Global X Fds 1-3 Month T-bill (CLIP)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)

View all positions for Bleakley Financial Group

Top funds holding Tango Therapeutics

Farallon Capital Management
Boxer Capital Management
Adage Capital Partners GP
TCG Crossover Management
BlackRock
Siren
Woodline Partners
Nextech Invest
Vanguard Group
Trv Gp Iv
State Street Corporation
Vanguard Capital Management
Goldman Sachs Group
Deerfield Management Company
Paradigm Biocapital Advisors

View all funds holding Tango Therapeutics